GROUP ONE TRADING, L.P. - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 46 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q2 2024$324,097
-17.5%
8,757
-6.4%
0.00%
-50.0%
Q1 2024$392,671
-54.0%
9,356
-56.6%
0.00%0.0%
Q4 2023$854,118
+74.8%
21,536
+21.3%
0.00%0.0%
Q3 2023$488,645
-54.1%
17,756
-43.4%
0.00%
-33.3%
Q2 2023$1,064,214
+47.0%
31,365
+55.9%
0.00%0.0%
Q1 2023$724,062
+131.8%
20,124
+187.2%
0.00%
+200.0%
Q4 2022$312,347
-19.5%
7,008
-49.2%
0.00%0.0%
Q3 2022$388,000
-49.2%
13,789
-51.3%
0.00%0.0%
Q2 2022$764,000
+13.4%
28,320
+43.2%
0.00%0.0%
Q1 2022$674,000
-61.4%
19,776
-56.3%
0.00%0.0%
Q4 2021$1,747,000
+18.8%
45,208
+65.9%
0.00%
-50.0%
Q3 2021$1,471,000
+67.3%
27,251
+3.7%
0.00%
+100.0%
Q2 2021$879,000
-48.4%
26,283
-68.2%
0.00%
-66.7%
Q1 2021$1,702,000
+302.4%
82,637
+242.1%
0.00%
+200.0%
Q4 2020$423,000
+2388.2%
24,159
+140.0%
0.00%
Q1 2020$17,000
-29.2%
10,065
-7.4%
0.00%
Q4 2019$24,000
-36.8%
10,870
-39.1%
0.00%
Q3 2019$38,000
+100.0%
17,837
+157.1%
0.00%
Q2 2019$19,000
-64.8%
6,937
-36.6%
0.00%
-100.0%
Q1 2019$54,00010,9480.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q1 2020
NameSharesValueWeighting ↓
Kynam Capital Management, LP 3,388,967$125,425,6699.68%
5AM Venture Management, LLC 497,270$18,403,9634.12%
COMMODORE CAPITAL LP 1,425,000$52,739,2503.60%
SILVERARC CAPITAL MANAGEMENT, LLC 374,910$13,875,4193.27%
TSP Capital Management Group, LLC 249,220$9,223,6352.89%
Eventide Asset Management 3,327,132$123,137,1552.11%
Affinity Asset Advisors, LLC 475,400$17,594,5542.03%
Novo Holdings A/S 850,000$31,458,5001.83%
Bellevue Group AG 2,971,615$109,979,4711.79%
Redmile Group, LLC 718,723$26,599,9381.61%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders